Mercado cerrado -
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
7,36 USD | +1,24 % |
|
-8,34 % | 0,00 % |
Resumen de negocios
Número de empleados: 100
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Peter Maag
CEO | Chief Executive Officer | 57 | 13/10/22 |
Ryan Jones
DFI | Director of Finance/CFO | 36 | 01/01/18 |
Dominic Borie
CTO | Chief Tech/Sci/R&D Officer | 61 | 01/01/20 |
Portia Serame
HRO | Human Resources Officer | - | - |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Beth Seidenberg
BRD | Director/Board Member | 67 | 01/09/18 |
Ian Clark
CHM | Chairman | 62 | 15/09/21 |
Dan Spiegelman
BRD | Director/Board Member | 65 | 01/04/21 |
Fred Cohen
BRD | Director/Board Member | 67 | 01/01/18 |
Peter Maag
CEO | Chief Executive Officer | 57 | 13/10/22 |
Brian Kotzin
BRD | Director/Board Member | 74 | 01/08/19 |
Dominic Borie
CTO | Chief Tech/Sci/R&D Officer | 61 | 01/01/20 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 43 115 244 | 38 471 716 ( 89,23 %) | 0 | 89,23 % |
Información de la empresa
![Dirección Kyverna Therapeutics, Inc.(KYTX)](https://cdn.zonebourse.com/static/address/165482092.png)
Sector
![Consenso](/images/consensus_flch.gif)
Revisiones del BPA
Varia. 1 de ene. | Capi. | |
---|---|---|
0,00 % | 317 M | |
+21,85 % | 46,44 mil M | |
+38,93 % | 39,1 mil M | |
-8,05 % | 38,76 mil M | |
+29,04 % | 31,24 mil M | |
-13,75 % | 25,8 mil M | |
+10,65 % | 25,9 mil M | |
+38,43 % | 13,12 mil M | |
-6,92 % | 11,32 mil M | |
-12,29 % | 10,68 mil M |
- Bolsa de valores
- Acciones
- Acción KYTX
- Empresa Kyverna Therapeutics, Inc.